CLINICAL_TRIALS
trial_result
· 2020-01-06
Clinical Trial Update: A Phase 2, Safety, Tolerability, and Efficacy Study of PD 0360324 in Chronic Pulmonary Sarcoidosis [Phase 2]
Summary
Phase 2 trial of PD 0360324 in chronic pulmonary sarcoidosis was terminated; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Pulmonary Sarcoidosis | Phase 2 | Status: TERMINATED | Results posted: 2020-01-06